Get the Stockscreener App
12.79
3.65%
0.45
After Hours:
13.18
0.39
+3.05%
Zymeworks Inc. Stock (ZYME) Latest News
Zymeworks sees over $2.8 million in stock purchases by EcoR1 Capital - Investing.com South Africa
Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Consensus PT from Brokerages - Defense World
Q1 Earnings Estimate for Zymeworks Issued By Lifesci Capital - Defense World
EcoR1 capital acquires $13.1 million in Zymeworks stock By Investing.com - Investing.com South Africa
EcoR1 capital acquires $13.1 million in Zymeworks stock - Investing.com India
Equities Analysts Issue Forecasts for Zymeworks Q1 Earnings - Defense World
Zymeworks (ZYME) Soars 5.4%: Is Further Upside Left in the Stock? - Nasdaq
Zymeworks (NYSE:ZYME) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Zymeworks (ZYME) with Outperform Recommendation - Nasdaq
Industry Analysts Just Upgraded Their Zymeworks Inc. (NASDAQ:ZYME) Revenue Forecasts By 13% - Simply Wall St
Zymeworks (NYSE:ZYME) Price Target Raised to $13.00 at HC Wainwright - Defense World
Deep Dive Into Zymeworks Stock: Analyst Perspectives (4 Ratings) - Benzinga
Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates - Yahoo Finance
Citigroup Boosts Zymeworks (NYSE:ZYME) Price Target to $19.00 - Defense World
Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251 - Benzinga India
Zymeworks Inc. (NYSE:ZYME) Q4 2024 Earnings Call Transcript - Insider Monkey
Zymeworks Inc (ZYME) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Insights - Yahoo Finance
Zymeworks Inc (ZYME) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Insights By GuruFocus - Investing.com Canada
Zymeworks Reports 2024 Financial Results and Pipeline Progress - TipRanks
Zymeworks Achieves FDA Approval for Ziihera® - TipRanks
Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates - MSN
Zymeworks Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Zymeworks Q4 2024 sees modest revenue, stock dips - Investing.com UK
Zymeworks Q4 Net Loss Widens, Revenue Increases; Shares Fall After Hours -March 05, 2025 at 04:55 pm EST - Marketscreener.com
Zymeworks Inc Q4 2024 Earnings: EPS of -$0.31 and Revenue of $31 - GuruFocus.com
Zymeworks shares fall as Q4 earnings miss expectations By Investing.com - Investing.com Canada
Zymeworks shares fall as Q4 earnings miss expectations - Investing.com India
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
How Will Zymeworks' FDA Win for Ziihera Impact Its $122M Annual Loss? - StockTitan
Rhumbline Advisers Buys 15,920 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks Inc (ZYME) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Zymeworks Inc.'s (NASDAQ:ZYME) Business Is Yet to Catch Up With Its Share Price - Simply Wall St
Zymeworks Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsZYME - ACCESS Newswire
Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration - Wahanariau
Zymeworks Achieves $14 Million in Milestone Payment From GSK Partnership -February 26, 2025 at 09:06 am EST - Marketscreener.com
Zymeworks Secures $14 Million Milestone from GSK Collaboration - TipRanks
Zymeworks to Engage Investors at Upcoming Conferences - TipRanks
Zymeworks Inc. Announces Participation in Upcoming Investor Conferences in March 2025 - Nasdaq
Zymeworks Announces Participation in Upcoming Investor Conferences - The Manila Times
Can Zymeworks' March Conference Circuit Signal New Clinical Progress? - StockTitan
Did Zymeworks Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateZYME - ACCESS Newswire
Zymeworks Inc. (NYSE:ZYME) Receives $19.17 Average Price Target from Brokerages - MarketBeat
Brokerages Set Zymeworks Inc. (NYSE:ZYME) Target Price at $19.17 - Defense World
Zymeworks Inc. Announces Appointment of Oleg Nodelman to the Board of Directors - Marketscreener.com
Zymeworks Welcomes Oleg Nodelman to Board of Directors - TipRanks
Zymeworks Announces Appointment Of Oleg Nodelman To Board Of Directors -February 18, 2025 at 06:18 am EST - Marketscreener.com
Zymeworks Inc. Appoints Oleg Nodelman to Board of Directors as Part of Ongoing Board Renewal Process - Nasdaq
Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors - GlobeNewswire
Major Strategic Move: Zymeworks Adds Largest Shareholder's Founder to Board, Signaling Growth Focus - StockTitan
Zymeworks BC Inc (ZYME) can make a big difference with a little luck - SETE News
Zymeworks (NYSE:ZYME) Stock Price Down 5.4%Should You Sell? - MarketBeat
Q1 Earnings Forecast for Zymeworks Issued By Leerink Partnrs - MarketBeat
Zymeworks to Announce 2024 Financial Results and Host Corporate Update - TipRanks
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):